PAHC
Phibro Animal Health Corp. - Ordinary Shares - Class A

278
Mkt Cap
$2.06B
Volume
503,483.00
52W High
$56.30
52W Low
$16.16
PE Ratio
22.50
PAHC Fundamentals
Price
$50.76
Prev Close
$52.38
Open
$52.09
50D MA
$47.29
Beta
1.12
Avg. Volume
330,642.33
EPS (Annual)
$1.19
P/B
6.19
Rev/Employee
$523,723.23
$1,723.43
Loading...
Loading...
News
all
press releases
Should You Continue to Hold Insulet Stock in Your Portfolio?
PODD's Omnipod 5 momentum and strong growth outlook highlight upside, but macro pressures and rising competition could challenge its near-term performance.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound?
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·2d ago
News Placeholder
GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging Capabilities
GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.
Zacks·2d ago
News Placeholder
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments
GKOS launches Epioxa, the first FDA-approved topical keratoconus therapy, targeting an underserved market and positioning the company for long-term growth.
Zacks·2d ago
News Placeholder
Phibro Animal Health (NASDAQ:PAHC) CEO Sells $369,740.80 in Stock
Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 7,040 shares of the stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $52.52, for a total value of $369,740.80. Following the completion of the transaction...
MarketBeat·3d ago
News Placeholder
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 10,560 Shares of Stock
Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 10,560 shares of the stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $52.68, for a total transaction of $556,300.80. Following the completion of the transaction, the...
MarketBeat·3d ago
News Placeholder
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 5,280 Shares of Stock
Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 5,280 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $51.66, for a total transaction of $272,764.80. Following the sale, the chief...
MarketBeat·3d ago
News Placeholder
ILMN Stock Gains Following Expanded Collaboration With Labcorp
Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer care.
Zacks·3d ago
News Placeholder
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·3d ago
News Placeholder
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
Zacks·3d ago
<
1
2
...
>

Latest PAHC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.